Damora Therapeutics Inc.

GLTO | NASDAQ

Price Alert Chart Builder DCF Calculator

$21.58

-$0.75 (-3.36%)

At close: Jun 4, 2026, 12:02 PM ET

Overview Rating Statistics Financials Earnings Analysts Ownership Profile

-3.36%

(1D)

Rating

Updated: May 8, 2026

21.5

Fundamentals Weak

Market Sentiment Neutral

Moat None

Full Analysis

Key Statistics

Market Data

Market Cap $34.47M

1D Range

21.58 23.54

52W Range

2.01 38.33

Valuation (TTM)

PE -1.08

PB 0.07

EV/EBITDA 2.08

Valuation (NTM)

Forward PE N/A

Forward PEG -0.06

Price Target $35.25

Cash Flow

FCF Yield -72.2%

SBC Adj. FCF Yield -74.6%

SBC Impact -3.3%

Margins

Gross Margin 0.0%

Operating Margin 0.0%

FCF Margin N/A

Growth (CAGR)

Revenue 3Y | 5Y N/A | N/A

Dil EPS 3Y | 5Y 20.1% | 31.2%

FCF 3Y | 5Y 18.0% | 21.6%

Returns

ROA -48.4%

ROE -82.6%

ROIC -52.4%

Financial Health

Net Cash

$531.56M

Current Ratio 19.73

Interest Coverage 0.00

Dividends

Div Yield N/A

Payout Ratio N/A

FCF Payout Ratio N/A

All Key Statistics

Loading financial charts...

Profile

A detailed description of the company is not yet available.

Sector n/a

Industry n/a

Employees n/a

IPO Date n/a

Website n/a

Fiscal Year n/a

Full Company Profile

Latest News

No news articles available yet.

Analyst Summary

# of Analysts

Consensus

Buy

Price Target

$42.50

Upside

+96.94%

Buy (1)

Hold (0)

Sell (0)

Analyst Details ➞